Retifanlimab (MGA-012) is a monoclonal antibody targeting programmed cell death protein 1 (PD-1). Retifanlimab is used in studies of Merkel cell carcinoma.
Purity:
>95.0%
CAS Number:
[2079108-44-2]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted